Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.

Discovery points toward treatment options beyond insulin injections

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Learn how NIBR uses next generation sequencing to transform clinical trials and diagnostics in oncology.

Novartis researchers aim to preserve kidney function – and quality of life – for patients.